OXB
LIVE

Serial Number

98606322

Owner

Oxford BioMedica plc

Attorney

Rebeccah Gan

Filing Date

Jun 18, 2024

Add to watchlist:

No watchlists yet
View on USPTO

OXB Trademark

Serial Number: 98606322 • Registration: 7855236

OXB is a trademark filed by Oxford BioMedica plc on June 18, 2024. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Oxford BioMedica plc (54 trademarks)

Medawar Centre, Robert Robinson Avenue
Oxford, OX4 4GA , GB

Entity Type: 03

Trademark Details

Filing Date

June 18, 2024

Registration Date

July 8, 2025

Published for Opposition

May 20, 2025

Goods & Services

Custom and contract manufacture of products relating to biotechnology, namely, gene therapy, and viral, retroviral, lentiviral and non-viral preparations and biopharmaceutical products, viral and non-viral vectors, and vaccines

Biotechnology research and laboratory analytic and diagnostic services in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; design of biotechnology manufacturing facilities; quality control and validation services in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; product development consultancy in the field of nanotechnology, gene therapy and vector-based delivery systems; product, viral vector and analytic assay development for others; laboratory services for biomanufacturing; research and development services for bio-manufacturing; genetic engineering laboratories and biochemistry laboratories; scientific and technological services and research in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; industrial analysis services in the field of biotechnology; provision of information relating to scientific research; providing scientific information in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; research and scientific analysis relating to drug discovery and development for others; scientific research and technology advisory services; scientific research and technology consultancy; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; management of scientific research projects; advisory services relating to scientific and clinical research; biological research; providing clinical and medical research information in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; clinical research in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; Scientific research in the nature of conducting clinical trials for others; bio-manufacturing development services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 8, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 8, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 20, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 20, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 14, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 16, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 16, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 16, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 16, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 16, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 19, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 18, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 24, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jan 24, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jan 24, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 13, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 12, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 12, 2025 NWOS
NEW APPLICATION ENTERED
Jun 18, 2024 NWAP